article thumbnail

PM360 Presents the 2024 Innovators

PM360

Established in 2012, PM360 introduced the first-ever issue focused entirely on our industrys latest innovations. Categories explore every sector of the healthcare industry, from life sciences to marketing. PM360 would like to welcome you to the new age of innovation with our illuminating Innovations Issue.

Marketing 100
article thumbnail

Understanding the evidence used in drug product withdrawals

European Pharmaceutical Review

Between 1999 and 2001, it supported 17 percent of withdrawals, between 2002 and 2011, it supported 26 percent of withdrawals and by 2012 to 2016, 80 percent of withdrawals were supported by observational studies (cohort, case-control, or other epidemiologic design). Meta-analyses contributed least frequently (31.4 2018; 8(1).

Medicine 116
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How to Thrive in the U.S. Medical Device Market With Stéphane Toupin

Evolve Your Success

Started a medical device distribution in 2012, covering all of Canada. Seventeen years in the pharmaceutical industry as a sales representative, sales manager, government affairs, market access, and training. Moved down to the USA in 2015. Partner in 2 other medical device distributions. As he says, “Enjoying life under the sun!”

Medical 130
article thumbnail

EC approves first-line ovarian cancer treatment

European Pharmaceutical Review

Thomas’ NHS Foundation Trust and King’s College London, London, UK, and European Network of Gynaecological Oncological Trial (ENGOT) lead of the ATHENA trial for rucaparib.

article thumbnail

How can evidence-based medicine (EBM) methodology support drug withdrawals?

European Pharmaceutical Review

Our research looked at products that were voluntarily withdrawn, or had their licence revoked or suspended within the EU for a safety reason between 2012 and 2016. The Human Medicines Regulations 2012, UK statutory instruments, 2012 No 1916, PART 5, Revocation, variation and suspension of marketing authorisation. Study focus.

article thumbnail

Anna Walz

Pharma Marketing Network

Anna was named a Top 100 PharmaVoice “most inspiring leader” in 2012. Website: [link] LinkedIn: [link] The post Anna Walz appeared first on Pharma Marketing Network. With Anna at the helm, MedEvoke has quickly become a leading partner to many top-20 pharmaceutical corporations.

article thumbnail

Fireside Chat with Dr. Joshua Liu, Co-founder & CEO at SeamlessMD

Impetus Digital

During his medical training at the University of Toronto, he co-led a research project at the University Health Network on hospital readmissions that inspired him to develop technology to help providers engage and monitor patients to prevent adverse outcomes, ultimately leading to him co-founding SeamlessMD in 2012.